Abstract
T(CD3+)-, B(CD19+)-lymphocytes and their subsets (CD4+, CD8+, CD3+, DR+, CD3− DR+) in peripheral blood of patients with CIN I, CIN II, CIN III and cancerin situ associated with HPV infection were evaluated. In peripheral blood of women with CIN II, CIN III and cancerin situ the number of T-lymphocytes which expressed CD3+ DR+ antigen decreased. In patients with CIN I, CIN III and cancerin situ the level of the CD4+ cells decreased; the level of the CD8+ cells increased. These patients had a lower CD4/CD8 ratio, the number of B cells being standard. The results may have important implications in the prognosis and immunotherapy of HPV infection.
Similar content being viewed by others
References
Bartholomew J.S., Stacey S.N., Coles B.: Identification of a naturally processed HLA A0201-restricted viral peptide from cell expressing human papillomavirus type 16 E6 oncoprotein.Eur. J. Immunol.24, 3175–3179 (1994).
Bosch F.E., Manoz M.M., Munoz N.: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.J. Nat. Cancer Inst.87, 796–802 (1995).
Boyum A.: Separation of leukocytes from blood and bone marrow.Scand. J. Clin. Lab. Invest.21, 28–33 (1968).
Chardonnet Y., Bejuithivolet F., Viac J.: Squamous epithelia and human papillomavirus infections.Pathol. Biol.40, 247–256 (1992).
Clerici M., Stocks N.I., Zajac R.A.: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients.J. Clin. Invest.84, 1892–1899 (1989).
Clerici M., Merola M., Ferrario E.: Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection limited to the cervix or involving other sites of the lower genital tract.J. Nat. Cancer Inst.89, 245–250 (1997).
Flander A.N., Adams M., Evans A.S.: Immunocompetent for immunotherapy—a study of the immunocompetence of cervical-cancer patients.Internat. J. Gynecol. Cancer5, 438–442 (1995).
Koutsky L.A., Holmes K.K., Critchlow C.W., Stevens C.E., Paavonen J., Beckmann A.M.: A control study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.New Engl. J. Med.327, 1272–1278 (1992).
Lakatosh V.P., Lazarenko L.N., Spivak N.Ya., Lyanenko L.A.: Immune response under HPV-infection and diseases of female genital organs associated with it.Likars'ka Sprava (Kiev)7, 25–36 (1998).
Lakatosh V.P.: Cryosurgical treatment of the benign processes of the cervix uteri associated with papillomavirus infection.Bull. Vinnytsia State Med. Univ.1, 96–97 (1999).
Lakatosh V.P., Lazarenko L.N., Lyanenko L.A., Dubchak V.E.: Present ideas on papillomavirus infection and its part in pathogenesis of pretumour and tumour processes in cervix uteri.Likars'ka Sprava (Kiev)2, 22–32 (1999).
Meisels A., Ruiz P.:HPV and Cervical Cancer, pp. 67–85 (1989).
Pinegin B.V., Minkina G.N., Korshunova O.V., Saprikin B.V., Saprikina O.A., Kulakov A.V., Bossart V., Karsonova M.I.: State of the local and system immunity in patients with papillomavirus cervical infection as affected by immunomodulator solkotrichovak.Immunologiya4, 45–48 (1997).
Rast W.M., Feltkamp M.C.W., Ressing M.E.: Cellular immunity against human papillomavirus-associated cervical cancer.Semin. Virol.7, 117–123 (1986).
Reid A., Stanhope C.R., Huschman B.R.: Colposcopia.Amer. J. Obstet. Gynecol.149, 815–823 (1984).
Soutter W.P., Kesic V.: Treatment of cervical intraepithelial neoplasia reverses CD4CD8 lymphocyte abnormalities in peripheral venous-blood.Internat. J. Gynecol. Cancer4, 279–282 (1994).
Stern P.L.: Immunity to human papillomavirus-associated cervical neoplasia.Adv. Cancer Res.69, 175–211 (1996).
Wu T.-C., Kurman R.J.: Analysis of cytokine profiles in patient with human papillomavirus associated neoplasms.J. Nat. Cancer Inst.89, 185–187 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spivak, M.Y., Lakatosh, V.P., Lazarenko, L.M. et al. Interrelation of lymphocyte subpopulations in peripheral blood under cervical papillomavirus infection. Folia Microbiol 44, 721–725 (1999). https://doi.org/10.1007/BF02825669
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02825669